Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Subclonal reconstruction from bulk tumor DNA sequencing has become a pillar of cancer evolution studies, providing insight into the clonality and relative ordering of mutations and mutational processes. We provide an outline of the complex computational approaches used for subclonal reconstruction from single and multiple tumor samples. We identify the underlying assumptions and uncertainties in each step and suggest best practices for analysis and quality assessment. This guide provides a pragmatic resource for the growing user community of subclonal reconstruction methods.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867630 | PMC |
| http://dx.doi.org/10.1038/s41592-020-01013-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ConvexML: Fast and accurate branch length estimation under irreversible mutation models, illustrated through applications to CRISPR/Cas9-based lineage tracing.
Syst Biol
August 2025
Computer Science Division, University of California, Berkeley, USA.
Branch length estimation is a fundamental problem in Statistical Phylogenetics and a core component of tree reconstruction algorithms. Traditionally, general time-reversible mutation models are employed, and many software tools exist for this scenario. With the advent of CRISPR/Cas9 lineage tracing technologies, there has been significant interest in the study of branch length estimation under irreversible mutation models.
View Article and Find Full Text PDFWhole‑exome evolutionary profiling of osteosarcoma uncovers metastasis‑related driver mutations and generates an independently validated predictive classifier.
J Transl Med
July 2025
The Key Laboratory of Biomarker High-Throughput Screening and Target Translation of Breast and Gastrointestinal Tumors, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
Background: Osteosarcoma is the most common primary malignant bone tumor, with high invasiveness and metastatic potential and a poor prognosis in patients with metastatic cancer. Despite the rapid advancements in genomics in recent years that provided new perspectives for studying the molecular mechanisms of osteosarcoma, the understanding of its tumor heterogeneity and evolutionary mutation process remains limited.
Methods: In this study, whole-exome evolutionary profiling was performed on data from the TARGET database representing 61 osteosarcoma cases.
Artificial Intelligence-Powered Insights into Polyclonality and Tumor Evolution.
Research (Wash D C)
July 2025
Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX 77030, USA.
Recent studies have revealed that polyclonality-where multiple distinct subclones cooperate during early tumor development-is a critical feature of tumor evolution, as demonstrated by Sadien et al. and Lu et al. in (October 2024).
View Article and Find Full Text PDFSubclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia.
Ann Hematol
July 2025
Univ Paris Est Créteil, INSERM, IMRB, Créteil, France.
The present longitudinal study reports a unique patient followed over almost three decades who sequentially developed polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia. The patient received successive hydroxyurea, ruxolitinib, and a combination of ruxolitinib and nilotinib. The clonal architecture dynamic was reconstructed using targeted high throughput asymmetric capture sequencing, allowing detection and quantification of mutations in 43 myeloid genes and BCR::ABL1 fusion in multiple bone marrow or peripheral blood samples and in single cell-derived colonies obtained from bone marrow colony-forming cell assays.
View Article and Find Full Text PDFGMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated and at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses.
Int J Mol Sci
April 2025
Hematology Research Center, Clinical Research Institute at Rambam, Rambam Health Care Campus, Haifa 3109601, Israel.
Acute myeloid leukemia (AML) is associated with unfavorable patient outcomes primarily related to disease relapse. Since specific types of leukemic hematopoietic stem and progenitor cells (HSPCs) are suggested to contribute to AML propagation, this study aimed to identify and explore relapse-initiating HSPC subpopulations present at diagnosis, using single-cell analysis (SCA). We developed unique high-resolution techniques capable of tracking single-HSPC-derived subclones during AML evolution.
View Article and Find Full Text PDF